Evidence map›Paper›PMID 21666822›Full record

ArticleTranslational stroke research2011

Resolving the negative data publication dilemma in translational stroke research.

Paul A Lapchak, John H Zhang

Abstract read
In one paragraph

Article in Translational stroke research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paul A LapchakTranslational Research, Cedars-Sinai Medical Center, Department of Neurology, Davis Research Building, Room D-2091, 110N. George Burns Road, Los Angeles, CA 90048, USA.
John H Zhang

Funding

Mechanisms of Hyperbaric Oxygen Induced Brain ProtectionR01NS043338 · NINDS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ZHANG, JOHN H · 2004 to 2014
$3.0M
Phenylpropanoid Analogs to Treat StrokeU01NS060685 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LAPCHAK, PAUL A · 2009 to 2014
$2.9M
Mechanisms of EPO-Induced NeuroprotectionR01NS054685 · NINDS · LOMA LINDA UNIVERSITY · PI ZHANG, JOHN H · 2007 to 2011
$1.8M
Neurovascular Protection for Subarachnoid HemorrhageR01NS053407 · NINDS · LOMA LINDA UNIVERSITY · PI ZHANG, JOHN H · 2006 to 2010
$1.8M
A Novel Family of Neuroprotective Compounds for StrokeR01NS060864 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SCHUBERT, DAVID R · 2009 to 2010
$1.6M
NINDS NIH HHS R01 NS043338NINDS NIH HHS R01 NS053407NINDS NIH HHS R01 NS054685NINDS NIH HHS R01 NS060864NINDS NIH HHS U01 NS060685
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID21666822
PMCPMC3109983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.